---
$id: https://graph.org.ai/products/commodity/51111734
$type: Product
source: UNSPSC
code: "51111734"
title: "Butantrone"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butantrone

**UNSPSC Code**: 51111734
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthraquinone compound with the molecular formula C18H16O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9P148IBA8M, chemically known as 10-butyryl-1,8-dihydroxyanthrone but generally known as butantrone, which bears US NIH Compound Identifier 53271. European Medicines Agency schedules Butantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06006MIG. The term BUTANTRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). BUTANTRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butantrone under HS 29145000 and SITC 51629. As of Q4 2014, BUTANTRONE remains the US FDA Preferred Term for this commodity. Butantrone bears US NLM identifiers UMLS ID C0044655 and NCI Concept Code C74164. SMILES: O=C(C1C2C(C(=O)C3C1CCCC3O)C(O)CCC2)CCC.

